These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14008063)

  • 21. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the anti-naupathic effect of a new preparation: xamethine].
    OTTOLENGHI S
    Ann Med Nav (Roma); 1960; 65():613-8. PubMed ID: 13731688
    [No Abstract]   [Full Text] [Related]  

  • 23. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of trimethobenzamide in nausea associated with neoplastic disease.
    MOLANDER DW
    Int Rec Med; 1961 Jan; 174():27-30. PubMed ID: 13771775
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nausea and vomiting: "the big little postoperative problem" of the surgical patient].
    Florescu A
    Chirurgia (Bucur); 2009; 104(2):127-9. PubMed ID: 19499654
    [No Abstract]   [Full Text] [Related]  

  • 27. Is the prophylactic use of antiemetics in surgical patients justified?
    ADRIANI J; SUMMERS FW; ANTONY SO
    JAMA; 1961 Feb; 175():666-71. PubMed ID: 13681534
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of radiation-induced nausea and vomiting.
    Abdelsayed GG
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic acupressure for management of postoperative nausea and vomiting: a preliminary study.
    Klaiman P; Sternfeld M; Deeb Z; Roth Y; Golan A; Ezri T; Azamfirei L
    Minerva Anestesiol; 2008 Nov; 74(11):635-42. PubMed ID: 18971892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 2004 Mar; 46(1179):27-8. PubMed ID: 15057189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
    Nieber K; Schoppmeyer K
    Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144
    [No Abstract]   [Full Text] [Related]  

  • 32. Postoperative nausea and vomiting.
    Kreis ME
    Auton Neurosci; 2006 Oct; 129(1-2):86-91. PubMed ID: 16942921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E
    J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of ondansetron, dexamethasone, ondansetron plus dexamethasone and placebo in the prevention of nausea and vomiting after laparoscopic tubal ligation.
    Biswas BN; Rudra A; Mandal SK
    J Indian Med Assoc; 2003 Nov; 101(11):638, 640, 642. PubMed ID: 15198411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Algorithms for the prevention of postoperative nausea and vomiting: an efficacy and efficiency simulation.
    Kranke P; Eberhart LH; Gan TJ; Roewer N; Tramèr MR
    Eur J Anaesthesiol; 2007 Oct; 24(10):856-67. PubMed ID: 17608963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients.
    Jakobsen JN; Herrstedt J
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):214-21. PubMed ID: 19162507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.